Table 2 Reported proportion of IMM compliance (%) and observed proportion of IMM target achievement (%) in responders and non-responders.

From: Differential expression of circulating exosomal microRNAs in refractory intracranial atherosclerosis associated with antiangiogenesis

Response

Baseline

1 month

6 months

Yes

No

Yes

No

Yes

No

IMM compliance

    antiplatelets

100.0

100.0

90.9

90.0

100.0

100.0

    statins

100.0

100.0

100.0

100.0

100.0

100.0

    BP medications

100.0

100.0

100.0

100.0

100.0

100.0

    DM treatment

100.0

100.0

100.0

100.0

81.8

80.0

IMM target achievementa

    LDL ≤ 70 mg/dL

54.5

50.0

72.7

60.0

54.5

 

    SBP ≤ 150 mmHg

63.6

70.0

54.5

60.0

63.6

 

    HbA1c ≤ 7%

63.6

70.0

72.7

80.0

72.7

 

    vigorous physical activity

27.3

20.0

36.3

40.0

54.5

 

    smoking cessation

72.7

80.0

81.8

100.0

100.0

 
  1. aThe target achievement was evaluated until any recurrence of ischemic event.
  2. IMM, intensive medical management; BP, blood pressure; DM, diabetes mellitus; LDL, low-density lipoprotein; SBP, systolic blood pressure; HbA1c, glycated hemoglobin A1c.